Industry 4.0 or pharma 4.0? Assessing suitability, benefits, challenges, and opportunities for healthcare supply chains

Muhammad Ibrahim Khan, Mirza Amin Ul Haq, Mustafa Rehman Khan, Arsalan Mujahid Ghouri, Raheel Farooqui

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

This chapter examines the convergence of Industry 4.0 and Pharma 4.0 in the context of healthcare supply chains. It investigates the potential applications of these industrial revolutions to enhance the flexibility, benefits, challenges, and opportunities of healthcare supply chains. This chapter highlights the application of state-of-the-art technology to create intelligent, adaptable, and personalized supply chain systems for the healthcare and pharmaceutical sectors. The literature on “Pharma Industry 4.0” is reviewed, with a focus on the opportunities for sustainable value creation and pharmaceutical supply chain research. Healthcare supply chain has some serious issues like counterfeit drugs, non-transparent supply chain, unfear track and trace system of medicines and biomedical instruments. The authors identified the potential solutions for these issues with the help of current innovative technologies and practices.
Original languageEnglish
Title of host publicationConvergence of Industry 4.0 and Supply Chain Sustainability
PublisherIGI Global
Pages319-341
Number of pages23
ISBN (Electronic)9798369313640
ISBN (Print)9798369313633
DOIs
Publication statusPublished - 19 Jan 2024

Publication series

NameAdvances in Logistics, Operations, and Management Science
ISSN (Print)2327-350X

Bibliographical note

Publisher Copyright:
© 2024, IGI Global. All rights reserved.

Keywords

  • Industry 4.0, Pharma 4.0, Assessing Suitability, Healthcare Supply Chains

Cite this